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of TPS. The collimator angle was changed from 0 to 170 degree, the 
leaf-speed was changed from 2.0 to 4.0 cm/sec. Then these plans 
were delivered to phantom and verified with three-dimensional 
detector: Delta4 (ScandiDos). All plans were delivered with a Varian 
Clinac 21EX linear accelerator equipped with Millenium multi-leaf 
collimator (MLC). The MLC motion logs during VMAT delivery were 
acquired and analyzed. The dose distributions were evaluated if those 
plans were acceptable for RTOG0615 dose tolerance or not. 
Results: As results of the plan comparison with several collimator 
angle settings, a single arc plan with collimator angle of 45 degree 
was acceptable for RTOG0615. On the other hand, all double arc plans 
were acceptable for RTOG0615. As results of the dosimetric 
verification by use of Delta4 detector, the passing rate of gamma 
analysis for the double arc plan with collimator angle 15/345 degree 
was worst in all plans. As results of comparison with various leaf-
speeds, the passing rates of gamma analysis were worse in plans with 
leaf-speed of more than 3.5 cm/sec.  
 
 Figure 1. The plan for dosimetric veification using Delta4 detector was 
created by Varian Eclipse TPS. 
Conclusions: The number of arc and maximum leaf-speed were 
affective factors for accurate dose delivery in VMAT plans. On the 
other hand, the setting of collimator angle was less affective 
parameter than those factors.  
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Purpose/Objective: The feasibility of using the Vero system for 
radiosurgery is yet unexplored. The high mechanical stability of the 
machine, the non-coplanar O-ring rotation liberty and the volumetric 
on-board imaging capabilities imply its use for intracranial 
stereotactic treatments. The Vero SBRT system was benchmarked in a 
planning study against a Novalis SRS system for quality of delivered 
dose distributions to intracranial lesions. 
Materials and Methods: A total of 27 patients with one single brain 
lesion treated on the BrainLAB Novalis system, with 3mm leaf width 
MLC and C-arm gantry, were re-planned for BrainLAB Vero, with a 
5mm leaf width MLC mounted on an O-ring gantry allowing rotations 
around both the horizontal and vertical axis. The Novalis dynamic 
conformal arc (DCA) planning included vertex arcs, using 90° couch 
rotation. These vertex arcs cannot be reproduced with Vero due to 
the mechanical limitations of the O-ring gantry. Alternative class 
solutions were investigated for the Vero (Figure 1). Additionally, to 
distinguish between the effect of MLC leaf width and different beam 
arrangements on dose distributions, the Vero class solutions were also 
applied for Novalis. The added value of IMRT was also investigated in 
this study. Quality of the achieved dose distributions was expressed in 
the conformity index (CI) and gradient index (GI), and compared using 
a paired Student t-test with statistical significance for p-values ≤ 
0.05.
 
Results: For the larger lesions, volumes > 5cm3 no statistical 
significant difference in conformity was observed between Vero and 
Novalis. For smaller lesions, the dose distributions showed a 
significantly better conformity for the Novalis (ΔCI=13.74%, p=0.0002) 
mainly due to the smaller MLC leaf width. IMRT on Vero reduces this 
conformity difference to non-significant levels compared to Novalis. 
The cut-off for realizing a GI of 3, characterizing a sharp dose fall-off 
outside the target volume was achieved for 4cm3 on Novalis and for 
7cm3 with the Vero using DCA technique. Using non-coplanar IMRT, 
this threshold was reduced to 3cm3 for the Vero system. 
Conclusions: The smaller MLC and the presence of the vertex fields 
allow the Novalis system to better conform the dose around the lesion 
and to obtain steeper dose fall-off outside the lesion. However, 
comparable dose dosimetric characteristics can be achieved on Vero 
for lesions larger then 3cm3 and using IMRT.  
   
EP-1206   
Step-and-Shoot IMRT segmentation method - impact on QA and dose 
distribution 
A.R. Figueira1, A. Monteiro1, A.L. Carvalho1, T. Reis1, V. Batel1, L. 
Alves1, P. Fontes1, P. Meireles1, G. Pinto1 
1Hospital de São João, Radiotherapy, Porto, Portugal  
 
Purpose/Objective: When Elekta CMS XiO TPS was improved (v.4.62) 
with an additional segmentation method for IMRT planning, Smart 
Sequencing (SS), we realized that the shape and delivery sequence of 
the segments produce by this method were considerably different 
from the ones produced with the other available method, Sliding-
Window (SW). The purpose of this work was to study this new 
segmentation method by comparing the plans produced with this 
option (SS plans) to the one we had before (SW plans), for a group of 
selected prostate patients. We evaluated the impact both on the 
achieved dose distributions and QA results. 
Materials and Methods: We selected a group of IMRT prostate 
patients and evaluated 2 typical situations in our department: 
patients treating only prostate and seminal vesicles (Type 1) and 
patients treating also pelvic nodes (Type 2). We used the CMS XiO 
(v.4.62) TPS to calculate alternative IMRT plans (SW vs. SS), both 
calculated using the same dose constraints for target volumes and 
organs at risk and distribution of fields. The plans were produced to 
be delivered in Siemens PRIMUS linear accelerator with 6 or 18 MV 
beams. The plans were compared analysing DVH for the target and 
organs at risks, according to ICRU 83 recommendations. The impact on 
IMRT QA was evaluated comparing point dose measurements, with an 
ion chamber, and plane dose distributions, using a 2D array. We 
compared measured vs. calculated dose to a point in the phantom, 
and gamma parameters such as mean gamma value and gamma 
passing rate. 
Results: For Type 1 cases, we were able to produce plans with 
equivalent dose distributions to PTV and OARs using both 
segmentation methods but, for all cases, using de SS method resulted 
in plans with a reduced number of segments and MUs, and thus 
reduced delivery times. The QA results were considered equivalent 
and all patients were treated with the plans produced with the SS 
methods manly because of the reduced delivery time. 
For Type 2 cases, although SS plans resulted in a reduced number of 
segments and MUs, the SW plans always resulted in better dose 
distributions, namely in terms of OARs sparing. All patients were 
treated with these plans. No significant differences were found in 
terms of IMRT QA. 
Conclusions: When treating regular target volumes, such as most 
prostate tumours (Type 1), the use of Smart Sequencing (SS) 
segmentation method resulted in dose distributions equivalent or 
better than those achieved with the Sliding Window (SW) method, 
always with reduced number of segments and MU. The associated 
reduction in the delivery time will eventually allow us to treat more 
prostate patients with IMRT. 
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When treating more complex target volumes, like pelvic nodes (Type 
2), we could not achieve better dose distributions with the SS method, 
namely in terms of OARs sparing and we were not able to take 
advantage of the reduced number of segments and MU, associated 
with the SS method. 
No significant differences were found in terms of IMRT QA.  
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Purpose/Objective: Objective of the present work is to evaluate the 
influence of increase in dose rate on dynamic IMRT plan quality and 
deliverability. 
Materials and Methods: Three previously treated patients of 
carcinoma prostate were chosen. Planning target volume (PTV) and 
organ at risk (OAR) i.e. bladder and rectum were contoured. Dynamic 
SIB-IMRT plans were created in Eclipse treatment planning system 
(TPS) for Varian CL2300C/D linear accelerator. Seven equi-spaced 
fields with 6MV photon beam at 300MU/min dose rate with 2.5cm/sec 
maximum allowable leaf velocity was used. The plan was then re-
optimized by keeping all the parameters constant, only dose rate was 
varied as follows: 400MU/min, 500MU/min and 600MU/min. 
Therefore, for each patient, four different plans were created. 
Prescription dose was 74Gy for PTV primary(PTV-P) and 54Gy for PTV 
Nodal (PTV-N) in 27 fractions and dose was prescribed at 95% isodose 
line. Plan quality was analyzed by means maximum and mean doses of 
PTV and OAR. Normal tissue integral dose (N.T.I.D.) (liter-Gray) of 
normal tissue volume (i.e., patient volume minus PTV-P and PTV-PA) 
was also calculated. Dose rate of 300MU/min was taken as reference. 
For accuracy of deliverability, treatment plans were verified with 
I’matriXX ion-chamber array and compared with TPS dose-plane by 
using gamma (γ) index of 3% dose difference and 3mm distance to 
agreement (DTA) criteria. Percentage of pixels passing gamma value 
up to 1(γ% ≤1) were noted. In addition, total monitor units (MUs) 
required to deliver a plan and machine beam ON time (min) were also 
noted. 
Results 
Results are summarized in Table-1 
 
Conclusions: There is no much dose difference was found for the PTV. 
However, slight difference was found for PTV-N maximum and mean 
doses. Similarly,increase in bladder mean dose, NTID and total 
number of MU increased with increase in dose rate. Beam ON time 
was lesser for higher dose rate. 2D gamma analysis showed almost 
comparable results for all dose rates.  
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Purpose/Objective: In 3D image-guided HDR gynaecological 
brachytherapy treatments, a consequence of the small size of the192Ir 
sources that are used for treatment combined with a steep dose 
gradient is that precise determination of source dwell positions 
becomes critical for accurate reconstruction of ring applicators. In 
comparison to CT and MRI which only allow for indirect reconstruction 
of applicators and consequent increase in associated reconstruction 
uncertainty, the use of film enables direct reconstruction of source 
dwell positions. This paper details a methodology and associated 
uncertainties relating to the reconstruction of ring applicators using 
gafchromic film. 
Materials and Methods: RTQA2 gafchromic films were attached to the 
surface of Nucletron interstitial ring applicators and irradiated at pre-
programmed dwell positions 1 cm apart in the configuration shown in 
figure 1. Four, three and one sets of Ø26 mm, Ø30 mm, and Ø34 mm 
ring applicators respectively were used for this study. The irradiated 
films were digitized using an Epson Expression 10000XL scanner. The 
coordinates of the source dwell positions were identified and the 
source path for the rings characterized by investigating correlations 
between the source path and movement of the source cable. 
Measurements were repeated over a period of nine months using three 
consecutive 192Ir sources and inter applicator and inter source dwell 
position differences investigated.  
 
  
Results: The source path was observed to deviate from the cable path 
by up to 30% leading to a cumulative deviation in expected source 
dwell position of at least 5 mm in all ring applicators. The inter 
applicator and inter source differences in source dwell positions were 
observed to be within the associated measurement uncertainties for 
the Ø30 mm and Ø34 mm ring applicators. Significant differences 
were observed between sets of the Ø26 mm ring applicators. The total 
expanded uncertainties associated with the determination of source 
positions in the applicators and presented in table 1, showed a 
maximum intra applicator average total expanded uncertainty (k=2) of 
1.14 ± 0.30 mm, 1.19 ± 0.14 mm and 1.04 ± 0.30 mm for the Ø26 mm, 
Ø30 mm and Ø34 mm ring applicator sets respectively. The inter 
applicator average total expanded unceratinty was also observed to 
be 1.07 ± 0.11 mm and 1.09 ±0.05 mm for the Ø26 mm and Ø30 mm 
ring applicators. 
 





























MAX. 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 1.000 
PTV-P 
MEAN 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 
PTV-N 
MAX. 1.000 1.000 1.000 1.001 1.000 1.001 1.002 1.002 1.000 0.999 0.999 1.000 
PTV-N 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 
BLADDER 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 
BLADDER 
MEAN 1.000 1.000 1.002 1.003 1.000 1.001 1.002 1.003 1.000 1.001 1.003 1.005 
RECTUM 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.002 1.002 
RECTUM 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.001 1.002 1.000 1.001 1.001 1.002 
N .T. 
I. D. 1.000 1.003 1.006 1.009 1.000 1.003 1.006 1.009 1.000 1.002 1.005 1.007 
PATIENT Patient 1 Patient 2 Patient 3  DOSE 
RATE 300 400 500 600 300 400 500 600 300 400 500 600 
TOTAL 
MU 
1565 
MU 
1931 
MU 
2024 
MU 
2112 
MU 
2254 
MU 
2337 
MU 
2426 
MU 
2513 
MU 
2322 
MU 
2389 
MU 
2468 
MU 
2552 
MU 
BEAM ON 
TIME  
6.78 
min. 
5.35 
min. 
4.43 
min. 
4.01 
min. 
7.80 
min. 
6.25 
min. 
5.15 
min. 
4.28 
min. 
7.83 
min. 
6.18 
min. 
5.10 
min. 
4.45 
min. 
γ INDEX 
(γ% ≤1) 
98.97 
% 
99.11
% 
98.95 
% 
99.02 
% 
99.78
% 
99.87 
% 
99.56 
% 
99.68
% 
99.48 
% 
99.39 
% 
99.44
% 
99.44 
% 
